ACCESS4ONE

Access4One is a partnership platform. It does not assume discovery alone solves affordability. It coordinates the functions that usually sit apart.

STEPS

 

STEP 1

Prioritize: identify therapies where affordability gains can be achieved quickly and measured clearly.

STEP 2

De-risk: align research, licensing, manufacturing, regulatory, and access partners around a lower-cost pathway.

STEP 3

Launch: support implementation through procurement, provider-system alignment, and patient-access design.

STEP 4

Recycle learning and savings: use evidence and efficiencies to expand the model and support future pilots.

BIOLOGICS BRIDGE

The first phase emphasizes cardiometabolic small molecules because they offer the best early probability of measurable gains within 36 months. Once those capabilities are proven, the same partner-coordination and access-design skills can support biologics and biosimilars.

JOIN US IN BUILDING THE NEXT GENERATION OF AFFORDABLE MEDICINE ACCESS

Access4One is building and scaling a practical, partnership-driven platform that lowers the cost of bringing essential medicines to patients.  We invite Donors and Partners to help create lasting, sustainable impact in the United States and around the World.